Related content

Clinical experience with trimegestone as a new progestin in HRT

By Grubb G.   Spielmann D.   Pickar J.   Constantine G.  

Steroids, Vol. 68, Iss. 10, 2003-11 ,pp. : 921-926

Elsevier

Access to resources Recommend Favorite

Omics Meets Biology: Application to the Design and Preclinical Assessment of Antivenoms

By Calvete Juan J.   Sanz Libia   Pla Davinia   Lomonte Bruno   Gutiérrez José María  

Toxins, Vol. 6, Iss. 12, 2014-12 ,pp. : 3388-3405

MDPI

Access to resources Recommend Favorite

Structure-Activity Relationships of Thiazolyl Resorcinols, Potent and Selective Inhibitors of Human Tyrosinase

By Mann Tobias   Scherner Cathrin   Röhm Klaus-Heinrich   Kolbe Ludger  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-02 ,pp. : 690-690

MDPI

Access to resources Recommend Favorite

Application of Organometallic Chemistry on Metal Surfaces to Fine Chemicals: A New Access to Trimegestone by Chemo-, Regio-, and Diastereoselective Hydrogenation of Cetaloxopromegestone on Pt/Sn/SiO₂ Catalysts

By Gertosio V.   Santini C.C.   Taoufik M.   Bayard F.   Basset J-M.   Buendia J.   Vivat M.  

Journal of Catalysis, Vol. 199, Iss. 1, 2001-04 ,pp. : 1-8

Academic Press

Access to resources Recommend Favorite

Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant

By Shelukhina Irina V.   Zhmak Maxim N.   Lobanov Alexander V.   Ivanov Igor A.   Garifulina Alexandra I.   Kravchenko Irina N.   Rasskazova Ekaterina A.   Salmova Margarita A.   Tukhovskaya Elena A.   Rykov Vladimir A.   Slashcheva Gulsara A.   Egorova Natalya S.   Muzyka Inessa S.   Tsetlin Victor I.   Utkin Yuri N.  

Toxins, Vol. 10, Iss. 1, 2018-01 ,pp. : 34-34

MDPI

Access to resources Recommend Favorite